InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,592.88
(
-1.31%
)
US TECH 100
19,308.80
(
-2.74%
)
Dow Jones
41,164.47
(
0.51%
)
Brent Oil
84.24
(
1.10%
)
Bitcoin
64,417.79
(
-1.03%
)
Post# of 199036
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

suny66

Send PM Follow Ignore
Followers 37
Posts 2257
Boards Moderated 0
Alias Born 05/10/2016

suny66

Re: None

Friday, 04/17/2020 11:36:26 AM

Friday, April 17, 2020 11:36:26 AM

Post# of 199036
Patented ITV-1 Technology. Immunotech BG-Europe , under the branded ImmunH , utilizing the technology has successfully completed Phase III clinical trials at the Specialized Hospital for Active Treatment of Infectious and Parasite Disease in Sofia, Bulgaria, specific for the treatment of HIV/AIDS.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENZC News
More ENZC News
InvestorsHub NewsWire

FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM

Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM

Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!